Top News
Latest News
MARKET TRENDS
5 Feb 2026
Into the Peptide Arena: Europe’s Next Pharma FightINSIGHTS
20 Jan 2026
GLP-1 Demand Powers Europe’s Peptide RevivalTECHNOLOGY
9 Jan 2026
A Digital Awakening in Europe’s Peptide IndustryRESEARCH
24 Dec 2025
EU Scientists Rethink Cancer With Peptide Power
A Transatlantic Tie Up Reshapes Peptide APIs
PARTNERSHIPS
15 Dec 2025
A new Lupin and PolyPeptide alliance positions Europe at the center of a more resilient global peptide API supply chain
MARKET TRENDS
5 Feb 2026
Into the Peptide Arena: Europe’s Next Pharma Fight
Europe’s peptide drug surge faces tougher pricing, fiercer rivals, and a scramble to scale manufacturing without losing momentum
INSIGHTS
20 Jan 2026
GLP-1 Demand Powers Europe’s Peptide Revival
PolyPeptide’s 15.6% revenue jump underscores Europe’s rising clout in peptide manufacturing as GLP-1 demand transforms supply chains
TECHNOLOGY
9 Jan 2026
A Digital Awakening in Europe’s Peptide Industry
Europe’s peptide makers embrace digital tools to boost quality and speed as demand for next generation therapies surges
RESEARCH
24 Dec 2025
EU Scientists Rethink Cancer With Peptide Power
EU scientists target tumor scaffolding with peptides, aiming to boost cancer therapies through novel combination strategies
PARTNERSHIPS
15 Dec 2025
A Transatlantic Tie Up Reshapes Peptide APIs
A new Lupin and PolyPeptide alliance positions Europe at the center of a more resilient global peptide API supply chain
REGULATORY
10 Dec 2025
Europe Draws Clear Lines for Synthetic Peptides
The EMA issues its first dedicated guideline for synthetic peptide drugs, clarifying quality and manufacturing rules from June 2026
SUBSCRIBE FOR UPDATES
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.